Paul Sargos, Head of the Radiology Department at Bergonie Institute, shared a post X about recent paper by him as co-author, titled “Concomitant Chemotherapy in Trimodal Treatment of Patients with Muscle Invasive Bladder Cancer: A Systematic Review of Prospective Trials” published on Science Direct.
Authors: Camille Baudelin, Paul Sargos, Derek Dinart, Christophe Hennequin, Diego Teyssonneau, Lucie Meynard, Nam-Son Vuong, Félix Lefort, Michael Baboudjian, Guilhem Roubaud.
“Our systematic review focusing on TMT and concomitant Chemo regimen for patients with MIBC
- Heterogeneity ++
- Overall, similar OS and safety outcomes
- Highest LOE=5FU-Mitomycin C
- Data regarding elderly patients and QOL insufficiently reported.”